• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

三十年的血液监测——成就与未来展望。

Thirty years of hemovigilance - Achievements and future perspectives.

作者信息

Vuk Tomislav, Politis Constantina, Laspina Stefan, Lozano Miquel, Haddad Antoine, de Angelis Vincenzo, Garraud Olivier

机构信息

Croatian Institute of Transfusion Medicine, Zagreb, Croatia.

Coordinating Centre for Haemovigilance and Surveillance of Transfusion, National Public Health Organization, Athens, Greece.

出版信息

Transfus Clin Biol. 2023 Feb;30(1):166-172. doi: 10.1016/j.tracli.2022.09.070. Epub 2022 Oct 8.

DOI:10.1016/j.tracli.2022.09.070
PMID:36216308
Abstract

Since its emergence in the early 1990s, hemovigilance has gradually evolved from a blood safety concept focused on surveillance of adverse reactions and events in patients, to a well-defined system that monitors the entire transfusion chain and improves its safety. The importance of hemovigilance has been recognized globally in a relatively short time, but the level of its implementation varies significantly between countries. The cooperation of international organizations has significantly contributed to the promotion, implementation, and education in this field. Thanks to initiatives taken, the safety of transfusion practice has been improved in many segments, primarily related to the risks of adverse events in recipients of blood components. In parallel with changing transfusion practice, the hemovigilance process has also matured. In addition to the reduction of existing risks and the early detection of emerging risks, hemovigilance has also embraced the principles of patient blood management. Research in hemovigilance is more increasingly focused on specific categories of patients, specific blood components and methods of their preparation, rare reactions, and transfusion efficacy and efficiency. A proactive approach and use of big data can play an important role in achieving these goals. Additional and sustained efforts should be made to prevent underreporting of events and to improve data comparability through clear definitions and grading systems. This review provides a historical overview of hemovigilance and its achievements, current challenges, and future plans.

摘要

自20世纪90年代初出现以来,血液监测已逐渐从一个专注于监测患者不良反应和事件的血液安全概念,演变为一个明确的系统,该系统监测整个输血链并提高其安全性。血液监测的重要性在相对较短的时间内已得到全球认可,但各国的实施水平差异很大。国际组织的合作对该领域的推广、实施和教育做出了重大贡献。由于采取了一系列举措,输血实践的安全性在许多方面都得到了改善,主要涉及血液成分接受者发生不良事件的风险。随着输血实践的不断变化,血液监测过程也日益成熟。除了降低现有风险和早期发现新出现的风险外,血液监测还纳入了患者血液管理的原则。血液监测研究越来越关注特定类别的患者、特定的血液成分及其制备方法、罕见反应以及输血效果和效率。积极主动的方法和大数据的应用在实现这些目标方面可以发挥重要作用。应做出更多持续努力,以防止事件报告不足,并通过明确的定义和分级系统提高数据的可比性。本综述提供了血液监测的历史概况及其成就、当前挑战和未来计划。

相似文献

1
Thirty years of hemovigilance - Achievements and future perspectives.三十年的血液监测——成就与未来展望。
Transfus Clin Biol. 2023 Feb;30(1):166-172. doi: 10.1016/j.tracli.2022.09.070. Epub 2022 Oct 8.
2
Transfusion-related adverse reactions: Data from the National Healthcare Safety Network Hemovigilance Module - United States, 2013-2018.输血相关不良反应:国家医疗保健安全网络血液监测模块的数据 - 美国,2013-2018 年。
Transfusion. 2021 May;61(5):1424-1434. doi: 10.1111/trf.16362. Epub 2021 Apr 20.
3
Transfusion-related adverse reactions reported to the National Healthcare Safety Network Hemovigilance Module, United States, 2010 to 2012.2010年至2012年向美国国家医疗安全网血液监测模块报告的输血相关不良反应。
Transfusion. 2015 Apr;55(4):709-18. doi: 10.1111/trf.12918. Epub 2014 Nov 5.
4
Proposing a Model for the National Hemovigilance Information System in Iran.为伊朗国家血液监测信息系统提出一种模型。
J Med Life. 2020 Apr-Jun;13(2):211-218. doi: 10.25122/jml-2019-0112.
5
Investigating the quality of hemovigilance process using the first two steps of Six Sigma model: a cross-sectional study.采用六西格玛模型的前两步调查血液警戒过程的质量:一项横断面研究。
BMC Health Serv Res. 2023 Oct 27;23(1):1169. doi: 10.1186/s12913-023-10113-6.
6
Transfusion-related errors and associated adverse reactions and blood product wastage as reported to the National Healthcare Safety Network Hemovigilance Module, 2014-2022.2014-2022 年向国家医疗保健安全网络血液监测模块报告的与输血相关的错误及相关不良反应和血液制品浪费。
Transfusion. 2024 Apr;64(4):627-637. doi: 10.1111/trf.17775. Epub 2024 Mar 12.
7
Transfusion and hemovigilance in pediatrics.儿科输血与血液监测。
Pediatr Clin North Am. 2013 Dec;60(6):1527-40. doi: 10.1016/j.pcl.2013.08.010.
8
Transfusion-Transmitted Infections Reported to the National Healthcare Safety Network Hemovigilance Module.国家医疗保健安全网络血液监测模块报告的输血传播感染。
Transfus Med Rev. 2019 Apr;33(2):84-91. doi: 10.1016/j.tmrv.2019.01.001. Epub 2019 Jan 25.
9
[International databases: usefulness and limitations in hemovigilance].
Transfus Clin Biol. 2010 Dec;17(5-6):306-9. doi: 10.1016/j.tracli.2010.09.158. Epub 2010 Nov 4.
10
Digitally enabled hemovigilance allows real time response to transfusion reactions.数字化的血液警戒系统可实时响应输血反应。
Transfusion. 2022 May;62(5):1010-1018. doi: 10.1111/trf.16882. Epub 2022 Apr 20.

引用本文的文献

1
Patient Blood Management after Hematopoietic Stem Cell Transplantation in a Pediatric Setting: Starting Low and Going Lower.儿科造血干细胞移植后的患者血液管理:从低起点开始并进一步降低。
Diagnostics (Basel). 2023 Jul 3;13(13):2257. doi: 10.3390/diagnostics13132257.
2
Big Data in Transfusion Medicine and Artificial Intelligence Analysis for Red Blood Cell Quality Control.输血医学中的大数据与红细胞质量控制的人工智能分析
Transfus Med Hemother. 2023 May 25;50(3):163-173. doi: 10.1159/000530458. eCollection 2023 Jun.
3
Is there any revival of the use of plasma therapy or neutralizing convalescent antibody therapy to treat SARS-CoV-2 variants and are we rethinking preparedness plans?
是否有恢复使用血浆疗法或中和康复期抗体疗法来治疗新冠病毒变种,我们是否正在重新思考防范计划?
Transfus Apher Sci. 2023 Jun;62(3):103726. doi: 10.1016/j.transci.2023.103726. Epub 2023 May 8.